Glutamate Transport Mechanisms in the Central Nervous System

Glutamate transport in the central nervous system (CNS) is essential for excitatory neurotransmission, metabolic support and prevention of excitotoxic injury. After release into the synaptic cleft, glutamate is rapidly cleared by specialised transport proteins located on astrocytes and neurons. These excitatory amino acid transporters (EAATs) exploit electrochemical gradients of sodium, potassium and protons to drive millisecond‐scale uptake of glutamate, maintaining low extracellular concentrations. Within astrocytes, glutamate is converted to glutamine and shuttled back to neurons in the glutamate–glutamine cycle. Structural studies reveal that conserved transport domains undergo large conformational changes—often described as an “elevator” mechanism—to translocate substrate and co‐transported ions across the membrane. Dysregulation of these transport processes underlies excitotoxic neuronal death, contributes to neuroinflammation and is implicated in conditions ranging from stroke and epilepsy to neurodegeneration. Understanding the coupling between ion binding, substrate recognition and conformational dynamics is central to therapeutic strategies aimed at modulating glutamate homeostasis.

Research from Nature Portfolio

High‐resolution cryo‐electron microscopy of human EAAT3 has defined previously unseen intermediate states in the transport cycle. These structures, captured with bound glutamate and symported sodium and proton ions or countertransported potassium, unveil an occluded conformation with dramatically enhanced substrate and ion affinity. This work clarifies how coordinated movements of gating hairpins and conserved amino acid motifs choreograph ion coupling and substrate translocation. In parallel, structural characterisation of the human neutral amino acid exchanger ASCT2—an SLC1 family member with an elevator‐type mechanism—has revealed that a single hairpin gate mediates both inward‐ and outward‐facing transitions. Identification of potential allosteric binding pockets around the scaffold domain offers avenues for selective modulation of transporter function in health and disease.

Glutamate Transport Mechanisms in the Central Nervous System publication trend

The graph below shows the total number of articles in glutamate transport mechanisms in the central nervous system across all publications each year (not limited to Nature Index journals).

Technical terms

Excitatory amino acid transporter (EAAT): A membrane protein that clears extracellular glutamate by co‐transporting sodium and protons and countertransporting potassium.

Elevator mechanism: A transport model in which the substrate‐binding domain moves across the membrane as a rigid body, carrying solutes between compartments.

Glutamate–glutamine cycle: The metabolic pathway in which astrocytes convert glutamate to glutamine for neuronal reuse, sustaining excitatory neurotransmission.

Excitotoxicity: Neuronal injury and death caused by excessive activation of glutamate receptors due to insufficient uptake.

Occluded state: A conformational intermediate in which substrate and ions are sealed within the transporter, isolated from both sides of the membrane.

References

1. Symport and antiport mechanisms of human glutamate transporters. Nature Communications (2023).
2. A one-gate elevator mechanism for the human neutral amino acid transporter ASCT2. Nature Communications (2019).
3. Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death. Redox Biology (2023).
4. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases. Journal of Medicinal Chemistry (2023).
5. Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release. Cells (2019).
6. Coupled ion binding and structural transitions along the transport cycle of glutamate transporters. eLife (2014).
7. Elevator-type mechanisms of membrane transport. Biochemical Society Transactions (2020).